Nick Curzen

University Hospital Southampton NHS Trust, Southampton, UK, and British Cardiovascular Intervention Society

Biography

Prof. Nick Curzen BM(hons) PhD FRCP is Professor of Interventional Cardiology at University of Southampton and Honorary Consultant Cardiologist at University Hospital Southampton NHS Foundation Trust. He is the current President of BCIS, having previously been a Council member, Education Lead, Research Lead and Honorary Secretary.

Nick specialises in coronary and aortic valve intervention.  

He pursues an active research programme:  Chief Investigator for RIPCORD2 and FORECAST randomised trials as well as for FFRCT RIPCORD & COMET. He also has active interests in platelet function, computer modelling of coronary stents and re-do TAVI implantation and coronary physiology. The research group contributes to many high profile multicentre trials. Nick has published over 320 PubMed papers and has edited 3 textbooks, including the Oxford Textbook of Interventional Cardiology.

Prof Curzen is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

Articles by Nick Curzen

Can Interventional Cardiologists Help Deliver the UK Mechanical Thrombectomy Interventional Programme for Patients with Acute Ischaemic Stroke? A Discussion Paper from the British Cardiovascular Interventional Society Stroke Thrombectomy Focus Group

Helen Routledge, Andrew SP Sharp, Jan Kovac, et al

Published:

Citation: Interventional Cardiology 2022;17:e07.

Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation

Philip MacCarthy, Dave Smith, Douglas Muir, et al

Published:

Citation: Interventional Cardiology Review 2021;16:e03.

Coronary Physiology Derived from Invasive Angiography: Will it be a Game Changer?

Lavinia Gabara, Jonathan Hinton, Julian P Gunn, et al

Published:

Citation: Interventional Cardiology Review 2020;15:e06.

An Extended Statement by the British Cardiovascular Intervention Society President Regarding the COVID-19 Pandemic

Nick Curzen,

Published:

Citation: Interventional Cardiology Review 2020;15:e01.

Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?

Mohammad Sahebjalal, Nick Curzen,

Citation: Interventional Cardiology Review 2015;10(3):136–8

Evidence for Benefit of Percutaneous Coronary Intervention for Chronically Occluded Coronary Arteries (CTO) – Clinical and Health Economic Outcomes

John Rawlins, James Wilkinson, Nick Curzen, et al

Citation: Interventional Cardiology Review 2014;9(3):190–4